Australia’s Sigma drops out of talks to buy UK’s Boots (opens original article in a new tab)

Australia's Sigma Healthcare has dropped its $10bn bid to acquire UK's Boots, citing strategic and capital investment reasons. The decision comes after a long period of uncertainty for Boots, which was put up for sale in 2022. Sigma's shares rose 6% following the announcement.

• Sigma Healthcare abandoned its $10bn takeover bid for Boots UK retail chain
• Boots has been under uncertainty since 2022 after its owner was acquired by Sycamore Partners
• Sigma's shares rose 6% after the decision to focus on existing growth opportunities
• Sigma previously merged with Chemist Warehouse to create a A$30bn pharmacy group